LASSO-TX (Lactation and Safe Sleep Opportunities in Texas) is a hospital-based quality improvement initiative of the Texas Collaborative for Healthy Mothers and Babies (TCHMB), in collaboration with the Texas Department of State Health Services.
This spring 2026, Mackenzie Senn, MPH, prepares to graduate with a Doctor of Philosophy in epidemiology from UTHealth Houston School of Public Health.
Qian Xiao, PhD, associate professor in Epidemiology, has been named a 2026-2027 U.S. Fulbright Program Scholar, a prestigious honor that supports international collaboration in research and education.
As Peyton HerrNeckar, a Master of Public Health student in environmental health, prepares to graduate from UTHealth Houston School of Public Health this spring 2026, his next chapter is already taking shape on the water.
February 27, 2026
UTHealth Houston School of Public Health researchers developed a new genetic framework model to improve the prediction of respiratory diseases among multi-ancestry populations, according to a new study.
February 27, 2026
UTHealth Houston School of Public Health researchers have developed a new genetic framework to improve the prediction of respiratory diseases among multi-ancestry populations, according to a new study.
February 23, 2026
The Heart Disease and Stroke Prevention Program at the UTHealth Houston Center for Health Promotion and Prevention Research is providing training to clinic staff at primary care clinics in Texas to equip them with practical, clinic-ready communication tools that have been proven to improve health outcomes related to hypertension.
February 20, 2026
UTHealth Houston again ranks among the nation’s leading institutions for National Institutes of Health research funding, according to the latest annual analysis by the Blue Ridge Institute for Medical Research.
February 6, 2026
A UTHealth Houston researcher reviewed existing scientific evidence on how exposure to “forever chemicals,” including per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs), may influence the risk of congenital heart defects in fetal cardiac development.
February 6, 2026
A UTHealth Houston researcher reviewed existing scientific evidence on how exposure to “forever chemicals,” including per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs), may influence the risk of congenital heart defects in fetal cardiac development.
January 26, 2026
After running a small pilot program for the past two years providing healthcare in laundromats, Jack Tsai, PhD, professor and regional dean in San Antonio, has secured a new $1.1 million grant to continue and expand the program for the next three years.
January 14, 2026
UTHealth Houston has been awarded more than $2.9 million from the Centers for Disease Control and Prevention (CDC) to continue and expand a five-year initiative focused on increasing colorectal cancer screening, follow-up, and treatment across Federally Qualified Health Centers (FQHCs) in Texas.
January 14, 2026
UTHealth Houston has been awarded more than $2.9 million from the Centers for Disease Control and Prevention (CDC) to continue and expand a five-year initiative focused on increasing colorectal cancer screening, follow-up, and treatment across Federally Qualified Health Centers (FQHCs) in Texas.
January 9, 2026
Since May 2025, second-year student at McGovern Medical School at UTHealth Houston, Yesmeena Shmaitelly, has played a pivotal role in advancing the Harris Health Food is Medicine (FIM) study, a multi-phased project providing fresh produce and nutrition education to at-risk pregnant mothers in the Greater Houston region.
